BMY shares fell 0.8% to $63.10 at the July 29, 2026 close, a slight decline from the prior close of $63.60. That close is the latest confirmed price for BMY; a live quote was not available. BestStocks flagged the session as a major change for BMY. The move is tied to an earnings beat. Below, we break down what changed for BMY, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
What happened
Earnings Beat
Bristol-Myers Squibb Company (BMY) reported EPS of $2.04 vs. consensus estimate of $1.60, beating by 27.5% on 2026-07-30. BMY's next earnings report is scheduled for 2026-10-29, with current consensus EPS estimate of $1.62.
This summary describes the catalyst and move as first detected on Jul 30, 2026, 10:25 AM EDT; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
Material / EarningsSector-Wide MoveLow confidence
Rel. volume
—
Calculating
Vs peers
Top 4 of 7 peers
In Line With Peers
Market cap
—
Earnings in
—
Price chart
Jun 29 – Jul 30
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details
What it means for BMY investors
For BMY investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Earnings beat — stock sold off (sell-the-news reaction); Positive price momentum. Weighing against that: Negative session, down 0.8%; Bristol-Myers Squibb Company (BMY) moved -4.03% from $59.34 to $56.95 on 2026-07-14. Because peers moved similarly, the shift looks more macro- or sector-driven than a change in BMY's fundamentals. BestStocks rates the overall signal quality low (49/100).
BMY price reaction
BMY last traded at $63.10, down $0.50 (-0.79%) from the previous close of $63.60. Its peer group moved a median -0.4% over the same stretch, leaving BMY essentially in line with peers. Over the past month the stock has ranged between $56.44 and $63.60, and it currently sits about 93% of the way up that band.
The bull and bear case for BMY stock
◆Latest catalyst·a mixed signal
The latest catalyst — an earnings beat the stock sold off — it cuts both ways, with the event and the market's reaction pointing in different directions.
Weighing the constructive signals against the risks, here is how the bull and bear case for BMY lines up on the latest data.
▲ The bullish case
+Earnings beat — stock sold off (sell-the-news reaction).
+Positive price momentum.
+Bristol-Myers Squibb Company (BMY) moved +1.28% from $60.16 to $60.93 on 2026-07-21.
▼ The bearish case
−Negative session, down 0.8%.
−Bristol-Myers Squibb Company (BMY) moved -4.03% from $59.34 to $56.95 on 2026-07-14.
−BMY fell 3.01% intraday to $56.80, with volume at 0.50x normal levels 90 minutes into the session.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish
The latest catalyst moved the balance toward the bulls — the hollow tick marks where it sat before.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Bristol-Myers Squibb Company (BMY) filed a new 8-K on July 30, 2026. The specific content of the filing was not disclosed in available sources.
Activity2026-07-30+0.0%
Bristol-Myers Squibb filed an 8-K material event report today alongside an earnings report, driving a +1.98% intraday gain to $64.35. Trading volume has reached 5.1 million shares — 3.15x the historical average for this time of session — signaling elevated institutional interest in the announcement.
Material / Earnings2026-07-27+0.8%
Bristol-Myers Squibb Company (BMY) moved +0.26% from $62.40 to $62.56 on 2026-07-27, reaching a new 30-day high. We checked news, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average.
Material / Earnings2026-07-24+0.9%
BMY moved +0.24% from its $61.94 open to a $62.09 close on 2026-07-24.
Material / Earnings2026-07-23+1.2%
Bristol-Myers Squibb Company (BMY) moved +1.27% from $60.74 to $61.51 on 2026-07-23, reaching a new 30-day high. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move appears aligned with strength in the broader pharmaceutical sector, where peers Merck (MRK) gained +3.34% and Johnson & Johnson (JNJ) gained +3.46% on the same day.
Activity2026-07-21+1.3%
Bristol-Myers Squibb Company (BMY) moved +1.28% from $60.16 to $60.93 on 2026-07-21. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move appears to be part of a broader sector rally, with peers LLY +2.46% and UNH +3.51% on the same day. BMY reached a new 30-day high, though volume remained near its 5-day average.
Activity2026-07-17+0.4%
Bristol-Myers Squibb Company (BMY) moved +0.38% from $60.51 to $60.74 on 2026-07-17. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. Seven sector peers moved in the same direction: AMGN +2.22%, MRK +3.15%, ABBV +4.29%, UNH +1.81%, indicating a sector-wide move. BMY reached a new 30-day high on normal volume.
Activity2026-07-16+3.0%
Bristol-Myers Squibb Company (BMY) moved +3.05% from $58.72 to $60.51 on 2026-07-16. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move appears to be part of a sector-wide rally: five pharma peers (AMGN +4.60%, MRK +5.67%, ABBV +3.93%, PFE +3.67%) moved in the same direction on the same day. BMY reached a new 30-day high; volume was near its 5-day average.
Upcoming catalysts & outlook
Next earnings
Unknown
Thesis shift
Neutral / Mixed
bearish signal
Risk level
High
from change events
Frequently asked questions about BMY
Why did BMY stock move?
BMY fell 0.8% to $63.10. The move is associated with an earnings beat and looks like a sector-wide move.
How much did BMY stock fall?
BMY lost 0.79% ($0.50) versus the prior close of $63.60, last trading at $63.10.
Is the BMY move company-specific or sector-wide?
BestStocks classifies it as a sector-wide move: the peer group moved a median -0.4% against BMY's -0.8%. BMY ranks top 4 of 7 peers.
How BestStocks tracks BMY
This page is generated automatically by BestStocks' change-detection system after an earnings beat was detected and verified against independent data sources. It draws on 19 tracked change events for BMY, cross-checked against the data sources listed below. A live intraday quote was not available, so price and volume figures are the confirmed end-of-day close from July 29, 2026 — not the current price — and the percentage move is that session's. They refresh once live quotes resume. For companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
